Onesource Specialty Pharma Ltd (ONESOURCE) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 544292 | NSE: ONESOURCE | Pharmaceuticals & Drugs | Small Cap

Onesource Specialty Share Price

1,685.55 14.05 0.84%
as on 05-Dec'25 16:59

Onesource Specialty Pharma Ltd (ONESOURCE) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 544292 | NSE: ONESOURCE | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Onesource Specialty

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Onesource Specialty Pharma stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
116.93
Market Cap:
19,149.1 Cr.
52-wk low:
1,163.1
52-wk high:
2,249.7

Is Onesource Specialty Pharma Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Onesource Specialty: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Onesource Specialty Pharma Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'23Mar'24Mar'25TTM
ROCE % -23.5%-21.3%3.7%-
Value Creation
Index
-2.7-2.6-0.7-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 38.71721,3001,510
Sales YoY Gr.-344.1%655.9%-
Adj EPS -94.7-80.58.414.3
YoY Gr.-NANA-
BVPS (₹) 194.797.2516.3522.6
Adj Net
Profit
-394-33495.9164
Cash Flow from Ops. -165-109-47.3-
Debt/CF from Ops. -5.1-5.2-16.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA655.9%
Adj EPS NANANANA
BVPSNANANA431.1%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'23Mar'24Mar'25TTM
Return on
Equity %
-50-56.432.8
Op. Profit
Mgn %
-391.2-47.228.334.4
Net Profit
Mgn %
-1016.7-194.47.410.9
Debt to
Equity
1.11.40.10.1
Working Cap
Days
0431152132
Cash Conv.
Cycle
097432

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Onesource Specialty Pharma Ltd.

Standalone Consolidated
TTM EPS (₹) 14.3 3.5
TTM Sales (₹ Cr.) 1,510 1,522
BVPS (₹.) 522.6 515.4
Reserves (₹ Cr.) 5,975 5,893
P/BV 3.20 3.24
PE 116.93 479.30
From the Market
52 Week Low / High (₹) 1163.05 / 2249.65
All Time Low / High (₹) 1163.05 / 2249.65
Market Cap (₹ Cr.) 19,149
Equity (₹ Cr.) 11.5
Face Value (₹) 1
Industry PE 40.7

Management X-Ray of Onesource Specialty:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *9.5820.0625.0126.04
* Pledged shares as % of Promoter's holding (%)

Valuation of Onesource Specialty - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Onesource Specialty

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25
Sales391721,300
Operating Expenses 199259932
Manufacturing Costs3738107
Material Costs2271408
Employee Cost 7379215
Other Costs 6872203
Operating Profit -161-88367
Operating Profit Margin (%) -414.0%-50.9%28.3%
Other Income 3420
Interest 4889162
Depreciation 6676135
Exceptional Items -158-116-112
Profit Before Tax -430-365-21
Tax 00-41
Profit After Tax -430-36520
PAT Margin (%) -1,109.6%-212.0%1.5%
Adjusted EPS (₹)-107.0-91.01.8
Dividend Payout Ratio (%)0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 7813905,908
Share Capital 4411
Reserves 7773865,896
Minority Interest000
Debt529281633
Long Term Debt335272219
Short Term Debt1949414
Trade Payables9581160
Others Liabilities 604557689
Total Liabilities 2,0081,3097,390

Fixed Assets

Gross Block1,6331,1393,611
Accumulated Depreciation271277410
Net Fixed Assets 1,3618633,200
CWIP 334188206
Investments 5202,848
Inventories13311153
Trade Receivables455442
Cash Equivalents 8060228
Others Assets 91111313
Total Assets 2,0081,3097,390

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'23Mar'24Mar'25
Cash Flow From Operating Activity -165-109-47
PBT -799-390-22
Adjustment 605288285
Changes in Working Capital 19-7-303
Tax Paid 110-7
Cash Flow From Investing Activity -66506-300
Capex -42-63-86
Net Investments -2760-91
Others 3510-123
Cash Flow From Financing Activity 118-384417
Net Proceeds from Shares 5650876
Net Proceeds from Borrowing -393-428-78
Interest Paid -105-103-152
Dividend Paid 000
Others 52147-229
Net Cash Flow -1121370

Finance Ratio

PARTICULARSMar'23Mar'24Mar'25
Ratios
ROE (%)-55.02-62.350.64
ROCE (%)-23.53-21.343.66
Asset Turnover Ratio0.020.10.3
PAT to CFO Conversion(x)N/AN/A-2.35
Working Capital Days
Receivable Days356369
Inventory Days1,25515323
Payable Days1,606455108

Onesource Specialty Pharma Ltd Stock News

Onesource Specialty Pharma Ltd FAQs

The current trading price of Onesource Specialty on 05-Dec-2025 16:59 is ₹1,685.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Onesource Specialty stood at ₹19,149.1.
The latest P/E ratio of Onesource Specialty as of 04-Dec-2025 is 116.9.
The latest P/B ratio of Onesource Specialty as of 04-Dec-2025 is 3.20.
The 52-week high of Onesource Specialty is ₹2,249.7 and the 52-week low is ₹1,163.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Onesource Specialty is ₹1,510 ( Cr.) .

About Onesource Specialty Pharma Ltd

OneSource Specialty Pharma Limited, formerly known as Stelis Biopharma Limited, is India’s first specialty pharma pure-play Contract Development and Manufacturing Organization (CDMO) business. By integrating Stelis’ Biologics CDMO, SteriScience's Complex Injectables, and Strides' Soft Gelatin businesses, it is positioned to deliver exceptional services to its customers. 

Following the NCLT process and listing, OneSource Specialty Pharma will operate state-of-the-art facilities in Bengaluru, India, all approved by major regulatory bodies, including the USFDA and EU authorities. Its comprehensive solutions span across platforms and therapeutic modalities, including Biologics, Drug-device combinations, Complex Injectables, and Oral Technologies. Committed to innovation and excellence, it supports global partners in delivering life-saving products efficiently.

Business area of the company

OneSource Specialty Pharma is a multimodal specialty pharma CDMO with end-to-end capabilities across technology platforms and therapeutic modalities.


To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×